Download | < Back |
13 Apr 2015 | |
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated April 13, 2015 titled "Suven initiated Multiple Ascending Dose (MAD) studies in Phase 1 clinical Trial for their investigational compound SUVN-G3031" | |
View all announcements for SUVEN LIFE SCIENCES LTD. | Source: BSE India |